• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CTI BioPharma Corp

+ Add to Watchlist

CTIC:US

2.4000 USD 0.0300 1.27%

As of 20:10:00 ET on 10/24/2014.

Snapshot for CTI BioPharma Corp (CTIC)

Open: 2.4000 Day's Range: 2.3700 - 2.4300 Volume: 623,777
Previous Close: 2.3700 52wk Range: 1.6000 - 4.2500 1-Yr Rtn: +25.65%

Stock Chart for CTIC

No chart data available.
  • CTIC:US 2.4000
  • 1D
  • 1M
  • 1Y
2.3700
Interactive CTIC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTIC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5113
Est. EPS (USD) (12/2014) -0.5660
Est. PEG Ratio -
Market Cap (M USD) 360.33
Shares Outstanding (M) 150.14
30 Day Average Volume 1,325,561
Price/Book (mrq) 20.8474
Price/Sale (ttm) 8.7827
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTIC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CTIC

CTI BioPharma Corp. is a biopharmaceutical company which provides medical research services. The Company develops and commercializes clinical treatment and drugs for various cancers such as ovarian, brain, neck, and breast.

James A BiancoPresident/CEO/Co-FounderLouis A BiancoExec VP/Chief Governance Ofcr
Jack W SingerExec VP:Global Medical AffairsMatthew J PlunkettExec VP:Corporate Development
More Company Profile & Key Executives for CTIC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil